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Metabolism and Toxicity of
Hydrochlorofluorocarbons: Current
Knowledge and Needs for the Future
by M. W. Anders*
Hydrochlorofluorocarbons (HCFCs) arebeingdevelopedasreplacementsforchlorofluorocarbons(CFCs)thatdeplete
stratospheric ozone. Thedepletionofstratospheric ozone mayincreasetheintensity ofultrvioletradiationattheearth's
surface, which may beassodatedwithglobal, adversehuman healtheffects. Thegreatertropospheric lability ofHCFCs,
whichisduetothe presenceofC-Hbonds, reducesHCFCmigrationtothestratosphere; HCFCsshould,therefore, cause
lessdepletionofstratospheric ozonethanCFCs. HCFCsunderdevelopmentincludeHCFC-22(chlorodifluoromethane),
HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane), HCFC-132b (1,2-dichloro-1,1-difluoroethane), HCFC-134a
(1,1,1,2-tetrafluoroethane), HCFC-141b (1,-dich l-fluoroethane, and HCFC-142b (1-chloro-1,1-duoroethane). With
theexceptionofHCFC-22, whichisalreadyinuse,themetabolismandtoxicity ofHCFCshavenotbeenstudiedindetail.
Byanalogy tochlorinatedethanes, predictionscanbemadeaboutthepossiblemetabbolismofHCFCs, butthere arein-
sufficient dataavailable to predict ratesofmetabolism. Although most HCFCs appear toshow low acutetoxicity, some
HCFCs aremutagenic intheAmestest. Hence, futureresearhonHCFCsshouldincludestudiesonthein vivoandin vibo
metabolism ofHCFCs as well as ontheir toxicity in in ivo and in vitro systems.
Introduction
Chlorofluorocarbons (CFCs) currently in use are per-
halogenatedalkanesthatfindextensive useinfourmajorapplica-
tions: as refrigerants, as blowing agents in the manufacture of
foamplastics, ascleaning fluids, and aspropellants. These ap-
plications exploit the useful physical properties of CFCs, in-
cluding lowboiling points, specific heats andheatsofvaporiza-
tion, high insulating value, low surfacetensionandviscosity, and
high vapor densities. Moreover, CFCs are nonflammable and
relatively freeofadversehealtheffects; reviewsaboutthetoxicity
ofCFCs have been published (1-3).
There iscurrently much concernaboutthepotentialeffectsof
CFCs on stratospheric ozone (4). Because of their chemical
stability, CFCsdo notdecompose inthetropospherebutrise to
the stratosphere where ultraviolet radiation catalyzes the release
ofchlorine atomsthatdestroy stratospheric ozone. Stratospheric
ozone is an important barrier against ultraviolet radiation and
reduces the amount ofultraviolet radiation that may otherwise
reach the earth. Depletion of the ozone layer may lead to in-
creased ultraviolet radiation at the earth's surface, and global
adversehumanhealtheffectsassociated with increased exposure
to ultraviolet radiation, such as an increase in skin cancer and
cataract formation, may be seen (5,6). These concerns have
prompted asearch forCFC replacements that arelessdamaging
to the ozone layer.
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Commercially importantCFCs includetheperhalomethanes
and ethanes fluorotrichloromethane (CFC-ll),* dichloro-
difluoromethane (CFC-12), 1,1,2-trichloro-l,2,2-trifluoroethane
(CFC-113), 1,2-dichloro-1,1,2,2-tetrafluoroethane (CFC-114),
and 2-chloro-1,1,1,2,2-pentafluoroethane (CFC-115). Some
CFCs haveestimated atmospheric lifetimes inthe tens to hun-
dredsofyears. Bromine-containingfluorocarbons, theso-called
halons, havegreaterozone-depleting potential than the CFCs,
butareusedtoalesserextent. AcapontheproductionofCFC-ll,
12, 113, 114, and 115 andaproductionfreezeonhalon-1211, 1301,
and240'2 wasmandatedbytheMontrealProtocolonSubstances
thatDepletetheOzoneLayerandbyEnvironmentalProtection
Agency regulations that became effective July 1, 1989 (8,9);
hencethere isasenseofurgency todevelopCFCreplacements.
Hydrochlorofluorocarbons (HCFCs) have been targeted as
replacements for CFCs currently in usebecauseofthe greater
lability imparted by the presence ofC-H bonds, which makes
them susceptible to oxidation in the troposphere, and because
SThenumeical codesforfluorocarbonshavebeenestablishedbytheAmerican
SocietyofRefrigerating Engineers (7). Briefly, the firstdigitontheright isthe
numberoffluorineatomsinthecompound, theseconddigitfromtherightisone
more than the numberofhydrogen atoms inthe compound, and thethirddigit
fromtheright, whichisomittedwhenthedigitiszero, isonelessthanthenumber
ofcarbonatoms inthecompound; thenumberofchlorineatomsisfoundby sub-
tractingthesumofthefluorineandhydrogenatomsfromthetotalnumberofatoms
thatcanbeconnectedtothecarbonatoms. Inthecaseofgeometric isomers, the
mostsymmetrical isomeris indicatedbythenumberalone; asisomersbecome
moreunsymmetrical, thelettersa, b, c, etc., areappended. Symmetry isdeter-
mined by summingtheatomic weightsofthesubstituents attached toeach car-
bonandby subtractingthesmallersumfromthelargersum; thesmallerthedif-
ference the more symmetrical the compound.M. W. ANDERS
theirphysicalpropertiesaresimilartoCFCs. CFCreplacements
cannot, however, benamedwithcertainty. Thetoxicological, en-
vironmental, andbasicthermodynamic propertiesofmostCFC
replacements have not been fully investigated, and further in-
vestigationsmay makesomepotentially usefulcompoundsun-
suitable forcommercialdevelopment. Moreover, cost-effective
synthetic methods thatcanbeappliedtothecommercial-scale
productionofHCFCsarenotavailableforallcompounds. Infor-
mation fromseveral sources indicatesthattheHCFCs listed in
Table 1, and whosechemical structures are shownin Figure 1,
are candidates fordevelopment (8-15).





Metabolism and Toxicityof HCFCs
Principles ofMetabolism ofHalogenated
Hydrocarbons
Work conducted over the past two decades has defined the
general metabolic pathways ofhalogenated hydrocarbons and
theirassociationwiththetoxiceffectsofhalogenatedhydrocar-
bons. Theseprinciples, which shouldbeequally applicable to
HCFCs, have been summarized (16,17).
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ve to be the dominant pathways ofmetabolism ofHCFCs and
may serve as detoxication or bioactivation reactions; the acyl
halides may acylate nucleophilic sites in protein, as has been
shownforchlorinatedanalogs(18,19). Intheabsenceofoxygen,
someHCFCsmayundergocytochromeP-450-catalyzedreduc-
tion reactions, as demonstrated for other polyhaloalkanes
(20-23); theexpectedinitialmetaboliteswouldbehaloalkanes
inwhichonehalogenhasbeenreplacedbyahydrogenorhalo-
ethenes formed by the didehalogenation of haloalkanes.
Haloalkenes formed by the didehalogenation of HCFCs may










ly, althoughHCFCscannot serveas substrates forglucuronyl-
or sulfotransterases, phase I functionalization reactions may
yield metabolites that are conjugated by, for example, glu-
curonideorsulfateesterformation.
Current Knowledgeand Speculations about
Metabolism
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FIGURE 1. Chemical structures ofhydrochlorofluorocarbons (HCFCs): HCFC-22, chlorodifluoromethane; HCFC-123, 2,2-dichloro-1,1,1-trifluoroethane;
HCFC-124, 2-chloro-1,1,1,2-tetrafluoroehane; HCFC-125, pentafluoroethane; HCFC-132b, 1,2-ichloro-1,1-difluoroethane; HCFC-134a, 1,1,1,2-etrafluoroethane;
HCFC-141b, 1,1-dichloro-l-fluoroethane; HCFC-142b, 1-chloro-l,l-difluoroethane.
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HCFC-22. The metabolism and toxicology of chloro-
difluoromethane hasbeen summarized (28). HCFC-22 shows
lowacutetoxicity invariousanimal species; aconcentrationof
20% HCFC-22 isnotlethaltoanyspeciestested(seeLitchfield
and Longstaff (28) for references to the original literature).
HCFC-22undergoeslittlemetabolisminvivo; lessthan0.03%
ofan inhaled dose of500 ppm [14C]- or [36C1]HCFC-22 was
metabolized (28). Pharmacokineticstudiesinratsdemonstrated
no detectable in vivo metabolism ofHCFC-22 (29). In vitro
studies with [36CI]HCFC-22 didnotshowthereleaseofdetec-
tablechlorideion,indicatingthatlittlemetabolismtakesplace.
HCFC-22(50,000ppmfor5hr/dayfor8weeks)doesnotaf-
fect male fertility in the rat nor is there evidence ofdominant
lethality (30). Exposure of rats to 50,000 ppm HCFC-22 (6
hr/dayondays6to 15ofpregnancy)producedalowincidenceof
microphthalmia and anophthalmia in rats; this effect was not
observed inrabbits (28).




otherexperiments (28). HCFC-22 isnotmutagenic inSchizo-
saccharomycespombe or in Saccharomyces cerevsiae or in a
host-mediatedassaywithS.pombeorS. cerevisiae(32). Similar-
ly, HCFC-22 was negative in an unscheduled DNA synthesis
assayinthehumanheteroploidEUEcelllineandinV-79Chinese
hamstercells (32)orinaCHOcellline(28,32). Theabilityof
HCFC-22 to induce chromosome damage in ratbone marrow
cells was studied (28); an apparent increase in chromosomal




posure ortodose, andthecompoundproduced itseffectinthe
premeiotic phase.
Recent studies report that no treatment-related effects were
seeninSprague-Dawley ratsorSwissmiceexposedtoHCFC-22
by inhalation (1,000or5,000ppmfor4hr/day, 5 days/weekfor
104 weeks) (33). HCFC-22 given by gavage (300 mg/kg, 5
days/week for 52 weeks) did not induce tumors during the
125-weekobservationperiod (34,35).
HCFC-23, I2, andDI Thelowestobservedlethalconcen-
tration of HCFC-123 is 14 pph/4 min in the mouse (36); ap-
parentlydataonthemammaliantoxicityofHCFC-124and 125
havenotbeenreported. HCFC-123, 124, and 125 arenotmuta-
genicintheAmestestwithS. typhimuriumTA1535orTA100as
theteststrains (35).
Because the pentahaloethanes HCFC-123, 124, and 125 are
analogsoftheanesthetichalothane(2-bromo-2-chloro-l,l,l-tri-
fluoroethane), considerableinsightintotheirpossiblemetabolic





rats. The adduct was identified as Ne-trifluoroacetyllysine.
Trifluoroacetic acid was identified as the only fluorine-con-




ofHCFC-123- and halothane-treated rats. These data indicate
thatHCFC-123 (Fig. 2A, X1 = X2 = Cl)andhalothane(Fig. 2A,
XI = Br, X2 = Cl)undergoacytochromeP450-catalyzedox-
ygenationtoanunstablegeminalhalohydrin(Fig. 2B,XI = Br
orCl,X2 = Cl),whichlosesHBrorHC toaffordtrifluoroacetyl
chloride (Fig. 2Q. Hydrolysis of acyl halide C gives tri-




reported, HCFC-124 may yield the geminal halohydrin
l-chloro-1,2,2,2-tetrafluoroethanol (Fig. 2B, Xl = Cl, X2 = F)

























FIGURE 2. Pathways fortheoxidativeandreductivemetabolismofHCFC-123(X, = X2 = C1), HCFC-124(XI = Cl, X2 = F), andHCFC-125(XI = X2 = F).
P-450,cytocbhmes P-450; Nu: tissuenucleophile.
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HCFC-125 may bemetabolized topentafluoroethanol (Fig. 2B,
X = X2 = F), whichmayloseHFtogivetrifluoroacetyl fluoride
(Fig. 2D, X2 = F)and,afterhydrolysis, trifluoroacetic acid(Fig.
2D).
Theoxidative metabolism ofhalothane is associated with the
formation ofhepatocyte membrane antigens, which may play a
role in halothane hepatitis (38,39); sera from patients and
animals exposed to halothane contain antibodies against
trifluoroacetylated proteins. Because HCFC-123, 124, and 125
may all be metabolized to trifluoroacetylating agents, it will be
important to determine whether there is cross-sensitization be-
tween HCFCs and halothane, as has been observed between
halothane and enflurane (40).
Halothane also undergoes cytochrome P-450-catalyzed reduc-
tive metabolism to2-chloro-1,1,1-triflluoroethane (HCFC-133a)
and to 2-chloro-1,1-difluoroethene in the presence of lowered
oxygen concentrations (20,21,41,42). This reaction is thought to
proceed viaacytochrome P450-catalyzed one-elecctron reduc-
tiontoan intermediate radical anion, which losesbromine togive
the l-chloro-2,2,2-trifluoroethyl radical. Abstraction of a
hydrogen atom from polyunsaturated lipids would yield the
observed metabolite 2-chloro-1,1,1-trifluoroethane, whereas the
homolytic elimination of fluorine would afford the alkene
2-chloro-1,1-difluoroethene, also a known metabolite of
halothane. By analogy with the metabolism of halothane, the
reductive metabolism ofHCFC-123 mayyield 2-chloro-1,1,1-tri-
fluoroethaneand2-chloro-I,j-difluoroethene (Fig. 2); the reduc-
tive metabolism ofHCFC-124 and 125 may yield1,1,1,2-tetra-
fluoroethane (HFCF-134a) andtrifluoroethene (Fig. 2). Whereas
it is possible to make qualitative predictions about the metabolic
fateofHCFC-123, 124, and 125, there is insufficientinformation
available to predict their rates of metabolism, although meta-
bolism usually decreases with increasing fluorination.
HCFC-132b. The lowest observed lethal concentration of
HCFC-132b is 20,000 ppm/4 hr in the rat (43). HCFC-132b
undergoes dechlorination (1.2%) when incubated with rat
hepatic microsomes (44). Rats exposed by inhalation to
HCFC132b (500,2,000, or 5,000 ppm for 6 hr/day, 5 days/week
for 13 weeks) showed proliferation ofbile duct epithelial cells,
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FIGURE 3. Pathways for the oxidative and reductive metabolism of
HCFC-132b (x = CO) and HCFC-134a (x = F). P-450, cytochromes P-450.
testicular damage, elevated liver-, heart-, kidney-, andlung-to-
body weightratios, decreased brain and testes weights, and low
activity and responsiveness to noise (45).
HCFC-132b undergoes extensive metabolism inthe rat (46).
The major metabolite was identified as 2-chloro-2,2-difluoro-
ethylglucuronide. Chlorodifluoroacetic acid was present in the
urine ofHCFC-132b-treated rats along with chlorodifluoroace-
taldehyde (Fig. 3A, X = Cl) may undergo oxygenation to yield
1,2-dichloro-2,2-difluoroethanol (Fig. 3B, X = Cl), which may
loseHCI togivechlorodifluoroacetaldehyde (Fig. 3C, X = Cl).
2-Chloro-2,2-difluoroethanol undergoes conjugation to form a
glucuronide and a sulfate ester. No detectable alkylation of
hepatic proteins was seen (46). These results areconsistent with
the generalization thatprotein acylation may be associated with
the metabolism of geminal dihaloethanes to acyl halides;
HCFC-132b should not be metabolized to an acyl halide and
wouldnot, therefore, beexpectedtoacylateproteins. Thetoxicity
of2-chloro-2,2-difluoroethanol has notbeeninvestigated, butthe
fluorinated analog 2,2,2-trifluoroethanol is toxic (47).
The cytochrome P-450-dependent reductive metabolism of
1,1,1,2-tetrachloroethane yieldsl,1-dichloroethene as the major
metabolite (23) and 1,1,2-trichloroethane as a minormetabolite
(22,48). These results areconsistent with thegeneralization that
chloroethanes with vicinal chlorine substituents may be reduc-
tively metabolized to haloalkenes by didechlorination (48). If
these generalizations apply to HCFCs, HCFC-132b may be
metabolized to 1,1-difluoroethene and 2-chloro-1,l-difluoro-
ethane (Fig. 3). 1,l-Difluoroethene induces the formation of
preneoplastic foci in rats, although the compound is much less
potent thanchloroethene (49).
HCFC-134a. HCFC-134a has been tested as an inhalational
anesthetic agentand reported to have nodirect toxic effects (50).
HCFC-134a is not mutagenic inthe Ames test (35). Thecytotox-
icity ofHCFC-134a has been studied in isolated rathepatocytes
(51). Head-space HCFC-134a concentrations 575% did not in-
crease lactate dehydrogenase release from hepatocytes. In
hepatocytes isolated from fed rats, HCFC-134a (e 12.5%) in-
creased glycolysis and the lactate/pyruvate ratio and decreased
glucoseproduction; inhepatocytes fromfasted rats, HCFC-134a
inhibited gluconeogenesis.
Recent studies on the metabolism of HFCF-134a have been
reported (52,53). HCFC-134a undergoes metabolism, as meas-
ured by the release of inorganic fluoride, in isolated rat
hepatocytes (52) and inrathepaticmicrosomes (53). HCFC-134a
defluorination in hepatocytes is proportional to the head-space
HCFC-134a concentration; with 50% HCFC-134a, fluoride
release amounted to 12 nmole F-/mg protein/ 2 hr. HCFC-134a
defluorination is decreased in heat-treated hepatocytes, is in-
hibited by pyrazole and halothane, and is increased in he-
patocytes isolated from phenobarbital-treated rats. In hepatic
microsomes, HCFC-134a defluorination is also proportional to
thehead-space HCFC-134aconcentration; with50% HCFC-134a,
fluoride release amounted to 6nmole F-/mg protein/15 min.
The microsomal metabolism ofHCFC-134a is inhibited by car-
bon monoxide, is decreased in the presence oflow oxygen con-
centrations, and is increased in microsomes isolated from
Aroclor-treated rats. These results indicate that HCFC-134a
undergoes a cytochrome P-450-catalyzed defluorination reac-
tion, andrecent studies implicatecytochrome P450 isoform IIEI
in the reaction (54).
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Although reaction mechanism studies have not yet been
reported, thecytochromeP-450-dependentoxidativemetabolism
ofHCFC-134a mayyield 1,2,2,2-tetrafluoroethanol, which may
lose HF to give trifluoroacetaldehyde; fluoride is a known
metaboliteofHCFC-134a(52,53). Trifluoroacetaldehydemaybe
reduced to 2,2,2-trifluorethanol or oxidized to trifluoroacetic
acid(Fig. 3). ThereductivemetabolismofHCFC-134amayyield
1,1-difluoroethene and 1,1,2-trifluoroethane asmetabolites (Fig.
3). The possible formation of 2,2,2-trifluoroethane as a
metaboliteofHCFC-134a isofparticular interestinviewofthe
observed gastrointestinal toxicity andhematotoxicity of2,2,2-
trifluoroethanol (47).
HCFC-141b. Themammaliantoxicity ofHCFC-141bhas not
beenstudied. HCFC-141bundergoesdechlorination(1.0%) when
incubated with rat hepatic microsomes (44). The chlorinated
analog 1,l,1-trichloroethane is metabolized to 2,2,2-trichloro-
ethanol, whichmaybeexcretedasitsglucuronideconjugate, and
to trichloroacetic acid in rats and humans (55,56). With rat
hepaticmicrosomal andnuclearfractionsastheenzymesources,
1,l,l-trichloroethane is metabolized to 2,2,2-trichloroethanol
(57,58). Based on these precedents, expected metabolites of
HCFC-141b include2,2-dichloro-2-fluoroethanol, which maybe
further oxidized to dichlorofluoroacetaldehyde and dichloro-
fluoroacetic acid(Fig. 4). Preliminary studies with '9F-NMRin
ratsexposedbyinhalationtoHCFC-141b showedthepresenceof
asingle fluorine-containing metabolite in urine inlow concen-
trations, which has tentatively been identified as2,2-dichloro-
2-fluoroethyl glucuronide (59). The toxicity of2,2-dichloro-
2-fluoroethanolhasnotbeenreported, but, asnoted, above, the
analog 2,2,2-trifluoroethanol is toxic (47).
HCFC-142b. The lowest observed lethal concentration of
HCFC-142b in the rat is 50 pph/30 min (60). HCFC-142b
undergoes dechlorination (0.6%) when incubated with rat
hepatic microsomes(44). HCFC-142bismutagenicintheAmes
testwith S. typhimuriumTA1535 orTA100asthetestorganisms
(35)andinaBHK21 cell-transformationassay (34,35). Ratsex-
posed to HCFC-142bby inhalation (100, 10,000, or20,000ppm
for 6 hr/day, 5 days/week for 13 or 15 weeks) did not show
compound-related effects inabonemarrowcytogenetic assay or
inadominantlethal assay(61). Notreatment-relatedeffectswere
observed in a90-day study ofrats anddogs exposedby inhala-
tion to HCFC-142b (1,000 or 10,000 ppm for 6 hr/day, 5
days/weekfor90days) (62)orina 104-weekstudyofratsexpos-
edby inhalation toHCFC-142b (1,000, 10,000, or20,000ppmfor
6 hr/day, 5 days/week for 104 weeks) (61).
Apart from the observation that HCFC-142b undergoes
dechlorination (44), themetabolismofHCFC-142bhasnotbeen
investigated. The cytochrome P-450-dependent oxidative
metabolism of HCFC-142b may yield 2-chloro-2,2-difluoro-
ethanol astheinitial metabolite, andchlorodifluoroacetaldehyde
cI Fc H
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and chlorodifluoroacetic acid may be formed by the further
metabolismofthetrihaloethanol (Fig. 4). Itshouldbenotedthat





With the exception ofHCFC-22, whosetoxicity has already
been extensively investigated, there are limited published tox-
icological data available about the HCFCs that have been pro-
posedas replacements forCFCs. Hencein vivotoxicity studies
onHCFCs areneeded; these studies should include short- and
long-termtoxicity studies, including, atleast, developmentaland
reproductive toxicity, neurotoxicity, carcinogenic potential,
mutagenicity, andimmunotoxicity. Theobjectiveofthesestudies
shouldbetoidentifytargetorgansthatareaffectedandthatmay
signal potentialhumanhealthhazards. Toxicity studiesinin vitro
systems (freshly isolatedcellsandculturedcell lines) shouldbe
conductedinparallelwithin vivotoxicitystudies, andthechoice
ofcells or cell lines to be used should reflect the target organs
observedininvivostudies. Theseinvitrostudiesshouldalsoin-
cludemutagenicity studiesinsubmammaliantestsystems. Final-
ly, in vitro systems may findutility inexploring possible mech-
anisms oftoxicity.
As noted above, recent studies indicate that metabolites of
HCFC-123 acylate hepatic proteins; because modification of
cellular macromolecules may be associated with cytotoxicity,
future studies shouldexaminefully theextentandnatureofthe
interactionsofHCFCmetaboliteswithcellularmacromolecules.
In addition, preliminary studies also indicate that 2-chloro-
2,2-difluoroethanol is ametabolite ofHCFC-132b; becausethe
analog2,2,2-trifluoroethanol istoxic (47), futurestudies should
addressthepotentialtoxicityof2,2,2-trihaloethanol metabolites
ofHCFCs.
Strategies for toxicity testing CFC replacements have been
proposed(63). Also, toxicity studiesarecurrently underway; the
multi-industry Program forAlternative FluorocarbonToxicity
Testing (PAFTT) is developing toxicity profiles for several
HCFCs (8).
Metabolism
Limited metabolic data are available for most HCFCs pro-











FIGURE 4. Pathway fortheoxidative metabolism ofHCFC-141b (X = Cl) and HCFC-142b (X = F). P-450Q cytochromes P-450; ADH, alcohol dehydrogenase;
Ald Ox, aldehyde oxidase.
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their possible interaction with cellular constituents, and the
mechanisms and routes of clearance of metabolites. In vivo
studies onthemetabolismofHCFCs may exploittheutility of
19F-NMR spectrometry in identifying free and tissue-bound
metabolites, asnotedabove(37,46,59). Theobjectiveofinvitro
metabolism studies, particularly in identifiedtargetorgans or
derivedcellsystems, shouldbetoidentifytheenzymescatalyz-
ing the metabolism ofHCFCs, possible associations between
metabolismandtoxicity , andinteractionsofHCFCmetabolites
with cellular macromolecules. Ultimately, studies on HCFC
metabolism shouldbeconductedwithpurifiedenzymesoren-
zyme systems so that reaction mechanisms canbeexplored in
detail. BecausetheHCFCsconstituteagroupofcloselyrelated
analogs, computational analysis ofdata from structure-me-
tabolism studies may be used to improve predictability ofthe
metabolicfateofHCFCs, interactionsofHCFCmetaboliteswith
cellular macromolecules, and relationships between HCFC
metabolism andtoxicity.
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